Search research articles
Contact Us
Filters
Showing results (51-60 of 78) with videos related to
Page
of 8
Sort By:
Veterinary and Comparative Oncology
|
September 17, 2009
Human granulocyte-macrophage colony-stimulating factor DNA cationic-lipid complexed autologous tumour cell vaccination in the treatment of canine B-cell multicentric lymphoma
M M Turek, D H Thamm, A Mitzey, et al.
Journal of Veterinary Internal Medicine
|
January 1, 1994
Alterations in lipoprotein profiles in dogs with lymphoma
G K Ogilvie, R B Ford, D M Vail, et al.
Cancer Immunology, Immunotherapy : CII
|
June 21, 2005
Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma
A N Alexander, M K Huelsmeyer, Ann Mitzey, et al.
Experimental Hematology
|
June 1, 1996
Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma
D M Vail, W C Kisseberth, J E Obradovich, et al.
Cancer
|
January 1, 1992
Effects of chemotherapy and remission on carbohydrate metabolism in dogs with lymphoma
G K Ogilvie, D M Vail, S L Wheeler, et al.
Journal of Veterinary Internal Medicine
|
February 22, 2008
Phase I clinical evaluation of carboplatin in tumor-bearing cats: a Veterinary Cooperative Oncology Group study
W C Kisseberth, D M Vail, J Yaissle, et al.
Journal of Veterinary Internal Medicine
|
April 3, 2004
Efficacy and toxicity of paclitaxel (Taxol) for the treatment of canine malignant tumors
V J Poirier, A E Hershey, K E Burgess, et al.
Veterinary and Comparative Oncology
|
April 23, 2014
Neurokinin-1 receptor expression and antagonism by the NK-1R antagonist maropitant in canine melanoma cell lines and primary tumour tissues
J F Borrego, M K Huelsmeyer, M E Pinkerton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 1999
Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model
A E Hershey, I D Kurzman, L J Forrest, et al.
Journal of the American Veterinary Medical Association
|
November 1, 1994
Evaluation of prognostic factors for dogs with synovial sarcoma: 36 cases (1986-1991)
D M Vail, B E Powers, D M Getzy, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 78) with videos related to
Sort By:
Page
of 8
Veterinary and Comparative Oncology
|
September 17, 2009
Human granulocyte-macrophage colony-stimulating factor DNA cationic-lipid complexed autologous tumour cell vaccination in the treatment of canine B-cell multicentric lymphoma
M M Turek, D H Thamm, A Mitzey, et al.
Journal of Veterinary Internal Medicine
|
January 1, 1994
Alterations in lipoprotein profiles in dogs with lymphoma
G K Ogilvie, R B Ford, D M Vail, et al.
Cancer Immunology, Immunotherapy : CII
|
June 21, 2005
Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma
A N Alexander, M K Huelsmeyer, Ann Mitzey, et al.
Experimental Hematology
|
June 1, 1996
Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma
D M Vail, W C Kisseberth, J E Obradovich, et al.
Cancer
|
January 1, 1992
Effects of chemotherapy and remission on carbohydrate metabolism in dogs with lymphoma
G K Ogilvie, D M Vail, S L Wheeler, et al.
Journal of Veterinary Internal Medicine
|
February 22, 2008
Phase I clinical evaluation of carboplatin in tumor-bearing cats: a Veterinary Cooperative Oncology Group study
W C Kisseberth, D M Vail, J Yaissle, et al.
Journal of Veterinary Internal Medicine
|
April 3, 2004
Efficacy and toxicity of paclitaxel (Taxol) for the treatment of canine malignant tumors
V J Poirier, A E Hershey, K E Burgess, et al.
Veterinary and Comparative Oncology
|
April 23, 2014
Neurokinin-1 receptor expression and antagonism by the NK-1R antagonist maropitant in canine melanoma cell lines and primary tumour tissues
J F Borrego, M K Huelsmeyer, M E Pinkerton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 1999
Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model
A E Hershey, I D Kurzman, L J Forrest, et al.
Journal of the American Veterinary Medical Association
|
November 1, 1994
Evaluation of prognostic factors for dogs with synovial sarcoma: 36 cases (1986-1991)
D M Vail, B E Powers, D M Getzy, et al.
Page
of 8